EBV latent membrane protein 1 is an attractive hypothesis as it up-regulates bcl-2, which has been shown to confer a survival advantage for lymphocytes in other lymphoproliferative disorders, and thus could enhance tissue lymphocyte accumulation and survival in LIP. Here, BCL2 is linked to oral cavity neoplasm.